Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Global Industrial Company reported Q3 2026 financial results with net sales increasing 10.2% to $389.5 million and diluted EPS rising 33.3% to $0.64. The company also declared a regular quarterly dividend of $0.28 per share and a special cash dividend of $1.00 per share.
Xometry, Inc. reported a significant revenue increase to $252.4 million for the third quarter of 2026, achieving a net income of $1.9 million compared to a net loss in the prior year period. The company's balance sheet was strengthened by a substantial increase in marketable securities, though it faces a current liability of $84.8 million for convertible notes due within the year.
Amerant Bancorp Inc. reported net income of $25.7 million for the third quarter of 2026, an increase from $14.8 million in the same period of 2025. Total assets grew to $10.2 billion, driven by loan growth, though stockholders' equity decreased to $840.8 million due to significant unrealized losses on debt securities available for sale.
Solid Power reported its Q3 2026 financial results, highlighting revenue and grant income of $1.2 million and a net loss of $24.4 million. The company reduced its full-year 2026 cash investment guidance to $75-$85 million and announced that commissioning of its MOBIUS continuous electrolyte production line is underway.
Term
Q3 2026
“The third quarter was marked by continued progress advancing our electrolyte technology and expanding our strategic relationships. We were excited to recently announce that commissioning of MOBIUS™, our next-generation continuous electrolyte production line, is underway.”
John Van Scoter, President and Chief Executive Officer
“We also advanced discussions regarding a potential joint venture in the Republic of Korea as we plan to establish commercial-scale electrolyte manufacturing capabilities. While EVs will continue to be our north star as we scale up, we are also actively pursuing new markets for our technology.”
John Van Scoter, President and Chief Executive Officer
CarGurus COO and President Samuel Zales Sells $323K of Stock
Samuel Zales, COO and President, sold 10,000 shares of CarGurus, Inc. at $32.33 a share, worth $323K in total on Nov 2, 2026. Shares held after the trade: 419,735 (-2.3%).
CubeSmart CLO & Secretary Jeffrey P. Foster Sells $996K of Stock
Jeffrey P. Foster, CLO & Secretary, sold 22,776 shares of CubeSmart at $43.72 a share, worth $996K in total on Nov 2, 2026. Shares held after the trade: 205,057 (-10.0%).
CubeSmart CFO Timothy M. Martin Sells $1.6M of Stock
Timothy M. Martin, CFO, sold 36,765 shares of CubeSmart at $43.51 a share, worth $1.6M in total on Nov 2, 2026. Shares held after the trade: 384,975 (-8.7%).
BlackRock ESG Capital Allocation Term Trust Insider Saba Capital Management L.P. Sells $1.17M of Stock
Saba Capital Management L.P. sold 86,172 shares of BlackRock ESG Capital Allocation Term Trust at $13.60 a share, worth $1.17M in total on Nov 2, 2026. Shares held after the trade: 12,166,941 (-0.7%).
Rockwell Medical Signs $125M M&A Deal with Vantive Limited
Rockwell Medical has entered into a definitive agreement to acquire Vantive Limited's global in-center hemodialysis business for a base purchase price of $125 million. The acquisition includes manufacturing facilities in Italy, operations in 35 jurisdictions, and a product portfolio spanning concentrates, machines, and water treatment systems. The deal is expected to transform Rockwell into a global provider with projected annual revenues between $400 million and $450 million.
Value
$125M
Counterparty
Vantive Limited
“Acquiring Vantive’s hemodialysis assets and associated operations represents a transformative step in Rockwell Medical’s evolution and directly advances the strategy we have been executing over the past several years.”
Mark Strobeck, Ph.D., President and Chief Executive Officer at Rockwell Medical
Fifth Third Bancorp filed its 10-Q for the period ending September 30, 2026, reporting 903,645,765 shares of common stock outstanding. The filing highlights significant risk factors including a pending merger with Comerica Incorporated and the impact of technology enhancements such as artificial intelligence.
Assembly Biosciences PFO and PAO Jeanette M. Bjorkquist Sells $14.1K of Stock
Jeanette M. Bjorkquist, PFO and PAO, sold 718 shares of Assembly Biosciences, Inc. at $19.61 a share, worth $14.1K in total on Nov 2, 2026. Shares held after the trade: 17,682 (-3.9%).
CarGurus Chief Product Officer Ismail Elshareef Sells $63.5K of Stock
Ismail Elshareef, Chief Product Officer, sold 1,964 shares of CarGurus, Inc. at $32.33 a share, worth $63.5K in total on Nov 2, 2026. Shares held after the trade: 123,670 (-1.6%).
U-Haul Holding 10% Owner Mark V. Shoen Sells $2.36M of Stock
Mark V. Shoen, 10% Owner, sold 46,000 shares of U-Haul Holding Co at $50.11 to $52.85 a share (average $51.31) in 4 transactions, worth $2.36M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 287,196 (-1.9%).
Atlas Energy Solutions Inc. reported a net loss of $45.1 million for the third quarter of 2026, compared to a net loss of $23.7 million in the prior year period. While total revenue increased slightly to $267.8 million, the company faced higher cost of sales and depreciation expenses, resulting in a significant decrease in gross profit.
InMed Pharmaceuticals M&A Deal with Mentari Therapeutics, Inc.
InMed Pharmaceuticals provided a status update on its pending merger with Mentari Therapeutics, which is expected to close in Q4 2026. Mentari has announced private placements totaling $490 million to support operations through 2029, and InMed shareholders will vote on the transaction at a meeting on November 4, 2026.
Counterparty
Mentari Therapeutics, Inc.
“We are approaching an important milestone in our proposed merger with Mentari Therapeutics, with our annual general and special meeting scheduled for November 4, 2026. Our focus remains on completing the transaction, which we believe provides shareholders with an opportunity to participate in the development of Mentari's migraine prevention pipeline.”
National Bank Holdings Corporation declared a quarterly cash dividend of $0.33 per share, representing an increase from previous levels. The dividend is payable on December 15, 2026, to shareholders of record as of November 27, 2026.
GXO Logistics reported Q3 2026 revenue of $3.6 billion, representing 6.4% organic growth, its highest in over three years. The company achieved $375 million in new business wins during the quarter and reaffirmed its full-year 2026 guidance for adjusted EBITDA and EPS.
Term
Q3 2026
“The new strategy we put in motion over the past year is delivering results: In the third quarter, we generated our fastest organic growth in more than three years, increased new business wins by more than 30% for the second consecutive quarter, and expanded our sales pipeline to a record level.”
Patrick Kelleher, chief executive officer of GXO
“At the same time, we are improving execution across the business, particularly in North America, and advancing the productivity initiatives that will support future margin expansion, including the rollout of a unified labor management system and the continued deployment of GXO IQ across our global footprint.”
Matrix Service Company held its 2026 Annual Meeting of Stockholders on November 3, 2026. Shareholders elected seven directors to serve until the 2027 Annual Meeting, ratified Deloitte & Touche LLP as the independent auditor for fiscal 2027, and approved executive compensation on an advisory basis.
Aptiv PLC reported net sales of $3,199 million for the quarter ended September 30, 2026, with net income attributable to Aptiv of $194 million. The period was marked by the spin-off of Versigent, resulting in a $1,893 million dividend and significant changes to the consolidated balance sheet, including the removal of discontinued operations assets and liabilities.
Kadant Inc. reported record third-quarter 2026 results, with revenue increasing 15% to $313 million and GAAP EPS rising 26% to $2.96. The company achieved record bookings of $291 million and raised its full-year 2026 adjusted EPS guidance to a range of $12.58 to $12.73.
Term
Q3 2026
“We delivered an exceptional third quarter, achieving record results across multiple key financial metrics, including revenue, adjusted EPS, and cash flow, while generating strong bookings growth across all three operating segments.”
Jeffrey L. Powell, chief executive officer of Kadant
“The strength of our aftermarket business, combined with disciplined execution and operational excellence, positions us well for a strong finish to the year.”
Jeffrey L. Powell, chief executive officer of Kadant
KeyCorp reported its financial results for the third quarter of 2026, highlighting its status as a large accelerated filer with over 1.05 billion common shares outstanding. The filing outlines the company's business segment performance across Consumer and Commercial banking, including updates on its capital markets activities and regulatory capital adequacy.
Standard BioTools reported a net income of $113.8 million for the nine months ended September 30, 2026, primarily driven by a $202.3 million gain on the sale of a business recorded in discontinued operations. However, the company experienced a loss from continuing operations of $57.7 million during the same period, reflecting ongoing restructuring and integration expenses.
Assembly Biosciences Chief Manufacturing Officer Nicole S. White Sells $50.3K of Stock
Nicole S. White, Chief Manufacturing Officer, sold 2,564 shares of Assembly Biosciences, Inc. at $19.61 a share, worth $50.3K in total on Nov 2, 2026. Shares held after the trade: 59,286 (-4.1%).
Rubrik Director John Wendell Thompson Sells $1.58M of Stock
John Wendell Thompson, Director, sold 13,500 shares of Rubrik, Inc. at $114.55 to $122.82 a share (average $117.27) in 14 transactions, worth $1.58M in total on Nov 2, 2026. Shares held after the trade: 8,362 (-2.3%).
Nucor Vice Pres. and Corp. Contro Michael D. Keller Sells $317K of Stock
Michael D. Keller, Vice Pres. and Corp. Contro, sold 1,136 shares of Nucor Corp at $279.33 a share, worth $317K in total on Nov 2, 2026. Shares held after the trade: 15,588 (-6.8%).
Capital City Bank Group, Inc. has published its third quarter 2026 Investor Presentation to its website and filed it as an exhibit to this 8-K. The presentation provides a strategic and operational update for investors following the conclusion of the third quarter.
ProShares Trust II announced a 1-for-2 reverse stock split for the ProShares VIX Mid-Term Futures ETF (VIXM), effective November 19, 2026. The split is part of a broader action by ProShares involving forward and reverse splits across 15 different ETFs to adjust share prices without changing total investment value. Fractional shares resulting from the reverse split will be redeemed for cash.
Pricesmart President and COO John D. Hildebrandt Sells $1.99M of Stock
John D. Hildebrandt, President and COO, sold 11,834 shares of Pricesmart Inc at $167.99 to $169.64 a share (average $168.23) in 2 transactions, worth $1.99M in total on Nov 2, 2026. Shares held after the trade: 101,699 (-9.0%).
The Procter & Gamble Company closed an underwritten public offering of four tranches of Euro-denominated notes totaling €3.25 billion in aggregate principal amount. The offering includes notes maturing in 2030, 2034, 2038, and 2046 with interest rates ranging from 3.750% to 4.625%.
Polomar Health Services announced that its financial statements for the first and second quarters of 2026 can no longer be relied upon due to accounting errors. The company identified unrecorded expenses, revenue recognition issues, and the misclassification of preferred stock, which are expected to increase its aggregate net loss by approximately $421,000. Polomar intends to restate these periods and expects to report one or more material weaknesses in its internal controls.